108 related articles for article (PubMed ID: 38848824)
1. Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells.
Hu WB; Liu YT; Li J; Wang Y; Sun XZ; Hua MY; Liu XT; Hui BN
Toxicol In Vitro; 2024 Jun; 99():105867. PubMed ID: 38848824
[TBL] [Abstract][Full Text] [Related]
2. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27
Tang Y; Chen J; Li J; Zheng Y; Zhong X; Huang S; Chen B; Peng B; Zou X; Chen X
Phytomedicine; 2021 Jun; 86():153563. PubMed ID: 33951569
[TBL] [Abstract][Full Text] [Related]
3. Pristimerin Exacerbates Cellular Injury in Conditionally Reprogrammed Patient-Derived Lung Adenocarcinoma Cells by Aggravating Mitochondrial Impairment and Endoplasmic Reticulum Stress through EphB4/CDC42/N-WASP Signaling.
Tang Y; Lei Y; Huang S; Li Z; Chen X; Luo H; Cheng C; Chen J; Zou X; Chen X
Oxid Med Cell Longev; 2020; 2020():7409853. PubMed ID: 32733636
[TBL] [Abstract][Full Text] [Related]
4. Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells.
Zhang Y; Wang J; Hui B; Sun W; Li B; Shi F; Che S; Chai L; Song L
Int J Mol Med; 2019 Mar; 43(3):1382-1394. PubMed ID: 30664149
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of pristimerin against LPS-induced acute lung injury in mice.
Shaaban AA; El-Kashef DH; Hamed MF; El-Agamy DS
Int Immunopharmacol; 2018 Jun; 59():31-39. PubMed ID: 29621734
[TBL] [Abstract][Full Text] [Related]
6. Effect of pristimerin on apoptosis through activation of ROS/ endoplasmic reticulum (ER) stress-mediated noxa in colorectal cancer.
Zhao Q; Bi Y; Guo J; Liu Y; Zhong J; Liu Y; Pan L; Guo Y; Tan Y; Yu X
Phytomedicine; 2021 Jan; 80():153399. PubMed ID: 33202325
[TBL] [Abstract][Full Text] [Related]
7. Pristimerin induces apoptosis of oral squamous cell carcinoma cells via G
Wu H; Li L; Ai Z; Yin J; Chen L
Oncol Lett; 2019 Mar; 17(3):3017-3025. PubMed ID: 30854080
[TBL] [Abstract][Full Text] [Related]
8. Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway.
Zhao Q; Cheng X; Yu W; Bi Y; Guo J; Ma Q; Gong Y; He L; Yu X
Phytomedicine; 2021 Nov; 92():153723. PubMed ID: 34482221
[TBL] [Abstract][Full Text] [Related]
9. ACP-5862 suppresses esophageal squamous cell carcinoma growth through inducing apoptosis via activation of endoplasmic reticulum stress and ROS production.
Liu Q; He J; Zhou X; Han M; Li J; Liu C; Yuan H
Biochem Biophys Res Commun; 2021 Jan; 534():995-1002. PubMed ID: 33168189
[TBL] [Abstract][Full Text] [Related]
10. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
Tu Y; Tan F; Zhou J; Pan J
Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
[TBL] [Abstract][Full Text] [Related]
11. Induction of cell-cycle arrest and apoptosis in human cholangiocarcinoma cells by pristimerin.
Sun JM; Xu HT; Zhao L; Zhang YB; Kang PC; Song ZF; Liu HS; Cui YF
J Cell Biochem; 2019 Jul; 120(7):12002-12009. PubMed ID: 30825242
[TBL] [Abstract][Full Text] [Related]
12. The 3-deoxysappanchalcone induces ROS-mediated apoptosis and cell cycle arrest via JNK/p38 MAPKs signaling pathway in human esophageal cancer cells.
Kwak AW; Lee MJ; Lee MH; Yoon G; Cho SS; Chae JI; Shim JH
Phytomedicine; 2021 Jun; 86():153564. PubMed ID: 33895649
[TBL] [Abstract][Full Text] [Related]
13. Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo.
Zhao Q; Liu Y; Zhong J; Bi Y; Liu Y; Ren Z; Li X; Jia J; Yu M; Yu X
Cell Death Discov; 2019; 5():125. PubMed ID: 31396402
[TBL] [Abstract][Full Text] [Related]
14. Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways.
El-Agamy DS; El-Harbi KM; Khoshhal S; Ahmed N; Elkablawy MA; Shaaban AA; Abo-Haded HM
Cancer Manag Res; 2019; 11():47-61. PubMed ID: 30588110
[TBL] [Abstract][Full Text] [Related]
15. Pristimerin Induces Autophagy-Mediated Cell Death in K562 Cells through the ROS/JNK Signaling Pathway.
Liu Y; Ren Z; Li X; Zhong J; Bi Y; Li R; Zhao Q; Yu X
Chem Biodivers; 2019 Aug; 16(8):e1900325. PubMed ID: 31290253
[TBL] [Abstract][Full Text] [Related]
16. Pristimerin reduces dextran sulfate sodium-induced colitis in mice by inhibiting microRNA-155.
Tian M; Peng S; Wang S; Li X; Li H; Shen L
Int Immunopharmacol; 2021 May; 94():107491. PubMed ID: 33770552
[TBL] [Abstract][Full Text] [Related]
17. Retrochalcone Echinatin Triggers Apoptosis of Esophageal Squamous Cell Carcinoma via ROS- and ER Stress-Mediated Signaling Pathways.
Kwak AW; Choi JS; Lee MH; Oh HN; Cho SS; Yoon G; Liu K; Chae JI; Shim JH
Molecules; 2019 Nov; 24(22):. PubMed ID: 31717502
[TBL] [Abstract][Full Text] [Related]
18. Daurisoline Inhibits ESCC by Inducing G1 Cell Cycle Arrest and Activating ER Stress to Trigger Noxa-Dependent Intrinsic and CHOP-DR5-Dependent Extrinsic Apoptosis via p-eIF2
Yuan S; Pan Y; Xu T; Zhang L; Chen X; Wang F; Liu Q; Jia L
Oxid Med Cell Longev; 2022; 2022():5382263. PubMed ID: 35965681
[TBL] [Abstract][Full Text] [Related]
19. Pristimerin alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease via inhibiting NF-κB pathway.
Huang D; Su L; He C; Chen L; Huang D; Peng J; Yang F; Cao Y; Luo X
Biochem Cell Biol; 2022 Jun; 100(3):223-235. PubMed ID: 35833632
[TBL] [Abstract][Full Text] [Related]
20. Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells.
Wang Y; Zhou Y; Zhou H; Jia G; Liu J; Han B; Cheng Z; Jiang H; Pan S; Sun B
PLoS One; 2012; 7(8):e43826. PubMed ID: 22952775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
